Literature DB >> 15834024

Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study.

T Nariai1, Y Matsushima, S Imae, Y Tanaka, K Ishii, M Senda, K Ohno.   

Abstract

BACKGROUND: The optimum management of patients with moyamoya disease remains controversial.
OBJECTIVES: To examine retrospectively the correlation between the degree of haemodynamic stress and the clinical presentation by measuring cerebral haemodynamics and metabolism using positron emission tomography (PET).
METHODS: 57 patients with moyamoya disease (mean age 32 years, range 12 to 64), classified into five groups according to clinical manifestations, underwent PET measurement of cerebral blood flow (CBF), cerebral blood volume (CBV), cerebral metabolic rate for oxygen (CMR(O2)), and oxygen extraction fraction (OEF) using (15)O labelled gases. The regional values in patient groups were compared with a normal group.
RESULTS: CBF in non-symptomatic patients, patients presenting with transient ischaemic attacks (TIA), and patients with haemorrhagic onset (H) was not significantly lower than in normal controls in any region. CBV in the TIA group and in patients with infarction associated with TIA (I/TIA) was significantly higher than in the controls in most regions. OEF in the frontal, parietal, and temporal cortex was significantly higher in the I/TIA group than in the controls. Patients in the H group and those with a permanent deficit with infarction (PD group) had decreased metabolism with normal OEF. Multivariate analysis to test the distribution of the three dimensional vector (CBF, CBV, OEF) showed significant differences between every possible pair among the six groups except NS v H and H v PD in the frontal cortex.
CONCLUSIONS: The haemodynamic status of moyamoya disease is not uniform, and severe haemodynamic stress occurs in selected subgroups of patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834024      PMCID: PMC1739646          DOI: 10.1136/jnnp.2003.025049

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

Review 1.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

2.  Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.

Authors:  Manus J Donahue; Michael Ayad; Ryan Moore; Matthias van Osch; Robert Singer; Paul Clemmons; Megan Strother
Journal:  J Magn Reson Imaging       Date:  2013-02-25       Impact factor: 4.813

3.  Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Authors:  M K Strother; M D Anderson; R J Singer; L Du; R D Moore; Y Shyr; T R Ladner; D Arteaga; M A Day; P F Clemmons; M J Donahue
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

4.  Imaging of cerebrovascular reserve and oxygenation in Moyamoya disease.

Authors:  Wendy W Ni; Thomas Christen; Jarrett Rosenberg; Zungho Zun; Michael E Moseley; Greg Zaharchuk
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with 15O-Gas PET and Singular Value Decomposition.

Authors:  S Hara; Y Tanaka; S Hayashi; M Inaji; T Maehara; M Hori; S Aoki; K Ishii; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-10       Impact factor: 3.825

6.  "Brush Sign" on susceptibility-weighted MR imaging indicates the severity of moyamoya disease.

Authors:  N Horie; M Morikawa; A Nozaki; K Hayashi; K Suyama; I Nagata
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

7.  Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with 15O-Gas PET and DSC-MRI.

Authors:  S Hara; Y Tanaka; Y Ueda; S Hayashi; M Inaji; K Ishiwata; K Ishii; T Maehara; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-16       Impact factor: 3.825

8.  Normal cerebral FDG uptake during childhood.

Authors:  Kevin London; Robert Howman-Giles
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-10       Impact factor: 9.236

9.  Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.

Authors:  Jai-Hyuck Han; Young Seok Park; Won Hyoung Lee; Sung-Soo Koong; Kyung-Soo Min; Mou-Seop Lee; Young-Gyu Kim; Dong-Ho Kim; Kyung-Sil Yi; Sang-Hoon Cha
Journal:  Childs Nerv Syst       Date:  2015-12-11       Impact factor: 1.475

10.  Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.

Authors:  Audrey P Fan; Jia Guo; Mohammad M Khalighi; Praveen K Gulaka; Bin Shen; Jun Hyung Park; Harsh Gandhi; Dawn Holley; Omar Rutledge; Prachi Singh; Tom Haywood; Gary K Steinberg; Frederick T Chin; Greg Zaharchuk
Journal:  Stroke       Date:  2017-08-01       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.